Low-thiamine diet increases mammary tumor latency in FVB/N-Tg(MMTVneu) mice

International Journal for Vitamin and Nutrition Research

Volumn 82, Issue 4, 2012, Pages 298-302

  Daily, Abigail ^a   Liu, Shuqian ^a   Bhatnagar, Saloni ^a   Karabakhtsian, Rouzan G ^a   Moscow, Jeffrey A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Breast cancer; Diet; Dietary fat; Thiamine; Vitamin

Indexed keywords

THIAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST TUMOR; CALORIC INTAKE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; LIPID DIET; LUNG METASTASIS; MOUSE; NONHUMAN; OBESITY; TUMOR VOLUME; VITAMIN BLOOD LEVEL; ANIMAL; BLOOD; DIET; EXPERIMENTAL NEOPLASM; FAT INTAKE; LUNG TUMOR; METASTASIS; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; DIET; DIET, HIGH-FAT; DIETARY FATS; FEMALE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; THIAMINE;

MLCS; MLOWN;

EID: 84878825995     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000122     Document Type: Article

References (23)

1. Liu, S., Huang, H., Lu, X., Golinski, M., Comesse, S., Watt, D., Grossman, R.B. and Moscow, J.A. (2003) Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol. Cancer Res., 1, 665-673.
2. Liu, S., Stromberg, A., Tai, H.H. and Moscow, J.A. (2004) Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. Mol. Cancer Res. 2, 477-487.
3. La Vecchia, C., Giordano, S.H., Hortobagyi, G.N. and Chabner, B. (2011) Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle. Oncologist, 16, 726-729.
4. Wolin, K.Y., Carson, K. and Colditz, G.A. (2010) Obesity and cancer. Oncologist 15, 556-565.
5. Neufeld, E.J., Fleming, J.C., Tartaglini, E. and Steinkamp, M.P. (2001) Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. Blood Cells Mol. Dis., 27, 135-138.
6. Kurtoglu, S., Hatipoglu, N., Keskin, M., Kendirci, M. and Akcakus, M. (2008) Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings. J. Pediatr. Endocrinol. Metab. 21, 393-397.
7. Ozdemir, M.A., Akcakus, M., Kurtoglu, S., Gunes, T. and Torun, Y.A. (2002) TRMA syndrome (thiamineresponsive megaloblastic anemia): a case report and review of the literature. Pediatr. Diabetes 3, 205-209.
8. Ricketts, C.J., Minton, J.A., Samuel, J., Ariyawansa, I., Wales, J.K., Lo, I.F. and Barrett, T.G. (2006) Thiamine- responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. Acta Paediatr. 95, 99-104.
9. Balakumar, P., Chakkarwar, V.A. and Singh, M. (2009) Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat. Mol. Cell Biochem. 320, 149-162.
10. Beltramo, E., Berrone, E., Tarallo, S. and Porta, M. (2008) Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol. 45, 131-141.
11. Du, X., Edelstein, D. and Brownlee, M. (2008) Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia 51, 1930-1932.
12. Nutrient Requirements for Laboratory Animals (1995) Fourth Revised Edition, p. 82, National Academy Press, Washington, D.C.
13. Lu, J. and Frank, E.L. (2008) Rapid HPLC measurement of thiamine and its phosphate esters in whole blood. Clinical Chemistry 54, 901-906.
14. Khalid, S., Hwang, D., Babichev, Y., Kolli, R., Altamentova, S., Koren, S., Goodwin, P.J., Ennis, M., Pollak, M., Sonenberg, N. and Fantus, I.G. (2010) Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis. Breast Cancer Res. Treat. 122, 647-659.
15. Cleary, M.P., Grande, J.P., Juneja, S.C. and Maihle, N.J. (2004) Diet-induced obesity and mammary tumor development in MMTV-neu female mice. Nutr. Cancer 50, 174-180.
16. Farber, S. (1949) Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood 4, 160-167.
17. Farber, S. and Diamond, L.K. (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N. Engl. J. Med., 238, 787-793.
18. Hernandez, B.Y., McDuffie, K., Wilkens, L.R., Kamemoto, L. and Goodman, M.T. (2003) Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12. Cancer Causes Control 14, 859-870.
19. Jedrychowski, W., Steindorf, K., Popiela, T., Wahrendorf, J., Tobiasz-Adamczyk, B., Kulig, J. and Penar, A. (2001) Risk of colorectal cancer from alcohol consumption at lower vitamin intakes. A hospital-based case-control study in Poland. Rev. Environ. Health 16, 213-222.
20. Kaaks, R., Tuyns, A.J., Haelterman, M. and Riboli, E. (1998) Nutrient intake patterns and gastric cancer risk: a case-control study in Belgium. Int. J. Cancer 78, 415-420.
21. Siassi, F., Pouransari, Z. and Ghadirian, P. (2000) Nutrient intake and esophageal cancer in the Caspian littoral of Iran: a case-control study. Cancer Detect. Prev. 24, 295-303.
22. Bruce, W.R., Furrer, R., Shangari, N., O'Brien, P.J., Medline, A. and Wang, Y. (2003) Marginal dietary thiamin deficiency induces the formation of colonic aberrant crypt foci (ACF) in rats. Cancer Lett. 202, 125-129.
23. Bruce, W.R., Cirocco, M., Giacca, A., Kim, Y.I., Marcon, N. and Minkin, S. (2005) A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation. Br. J. Cancer 93, 639-646.